Global Chemotherapy Drugs Market Report

Global Chemotherapy Drugs Market: Analysis By Drug Type (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics), By Administration (Oral, Intravenous), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023)

• By Region - North America, Europe, Asia

Pacific, Rest of the World. • By Country - U.S.A, Canada, Germany, U.K, Japan, China, India.

March 20191

Scope of the Report – Chemotherapy Drugs Market Historical

Forecast

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Antimetabolites























Plant Alkaloids























Alkylating Agents























Antitumor Antibiotics























Others























Oral























Intravenous























Others























Antimetabolites























Plant Alkaloids























Alkylating Agents























Antitumor Antibiotics























Others























Global

Market (By Value)

By Type of Drug,

By Value

Regional

By Route of Administration,

By Value

By Type of Drug,

By Value

2

Scope of the Report – Chemotherapy Drugs Market Historical

Forecast

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Oral























Intravenous























Others























Regional

Market (By Value)

By Route of Administration,

By Value

Pfizer Inc. (U.S.), Eli Lilly & Company (U.S.), Sanofi (France), Novartis (Germany), GlaxoSmithKline (U.K.), Bristol-Myers Squibb , Company Analysis

Teva Pharmaceuticals Industries (Japan), F. Hoffmann-La Roche Ltd ( Switzerland), Merck & Co., Inc. (U.S.), CELGENE CORPORATION (U.S.), Amgen Inc (U.S.), Takeda Pharmaceutical Company Limited (Japan),

Regional Analysis

North America, Europe, APAC and Rest of the World

Country Analysis

U.S.A, Canada, Germany, U.K, Japan, China and India.

3

Table of Content S.No

Particulars

Page No.

1.

Research Methodology

19

2.

Executive Summary

20

3.

Strategic Recommendation

21

3.1

Focus on promoting oral chemotherapy drugs

22

3.2

APAC region to witness augmented growth in the forecast period

23

4.

Chemotherapy Drugs Market Outlook

24

5.

Global Chemotherapy Drugs Market: Growth and Forecast

24

6.

5.1

By Value (2013-2017)

35

5.2

By Value (2018-2023)

36

Global Chemotherapy Drugs Market: Segmental Analysis

47

6.1

Global Antimetabolite Chemotherapy Drugs Market, By Value (2013-2023)

49

6.2

Global Plant Alkaloid Chemotherapy Drugs Market, By Value (2013-2023)

50

4

Table of Content S.No

7.

Particulars

Page No.

6.3

Global Antitumor Antibiotic Chemotherapy Drugs Market, By Value (2013-2023)

51

6.4

Other Chemotherapy Drugs Market, By Value (2013-2023)

52

6.5

Global Chemotherapy Drugs Market Size, By Route of Administration: Breakdown (%)

53

6.5.1

Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)

55

6.5.2

Global Chemotherapy Drugs Market Size, By Route of Administration, 2023 (%)

56

6.6

Global Intravenous Chemotherapy Drugs Market, By Value (2013-2023)

57

6.6

Global Oral Chemotherapy Drugs Market, By Value (2013-2023)

58

6.7

Other Chemotherapy Drugs Market, By Value (2013-2023)

59

Global Chemotherapy Drugs Market: Regional Analysis 7.1

Global Chemotherapy Drugs Market Size, By Region : Breakdown (%)

60 61

7.1.1

Global Chemotherapy Drugs Market Size, By Region, 2017 (%)

62

7.1.2

Global Chemotherapy Drugs Market Size, By Region, 2023 (%)

63

5

Table of Content S.No

Particulars 7.2

7.3

7.4

Page No.

North America Chemotherapy Drugs Market: Growth and Forecast

64

7.2.1

By Value (2013-2017)

65

7.2.2

By Value (2018-2023)

66

7.2.3

By Type of Drug, By Value (2013-2017)

72

7.2.4

By Type of Drug, By Value (2018-2023)

73

7.2.5

By Route of Administration, By Value (2013-2017)

74

7.2.6

By Route of Administration, By Value (2018-2023)

75

North America Chemotherapy Drugs Market: Country Analysis (U.S and Canada) 7.3.1

U.S Chemotherapy Drugs Market, By Value (2013-2023)

7.3.2

Canada Chemotherapy Drugs Market, By Value (2013-2023)

Europe Chemotherapy Drugs Market: Growth and Forecast

76 78

86

92

6

Table of Content S.No

Particulars

7.5

7.6

Page No.

7.4.1

By Value (2013-2017)

93

7.4.2

By Value (2018-2023)

94

7.4.3

By Type of Drug, By Value (2013-2017)

100

7.4.4

By Type of Drug, By Value (2018-2023)

101

7.4.5

By Route of Administration, By Value (2013-2017)

102

7.4.6

By Route of Administration, By Value (2018-2023)

103

Europe Chemotherapy Drugs Market: Country Analysis (Germany and U.K)

104

7.5.1

Germany Chemotherapy Drugs Market, By Value (2013-2023)

106

7.5.2

U.K Chemotherapy Drugs Market, By Value (2013-2023)

111

APAC Chemotherapy Drugs Market: Growth and Forecast 7.6.1

By Value (2013-2017)

116 117

7

Table of Content S.No

Particulars

7.7

7.8

Page No.

7.6.2

By Value (2018-2023)

118

7.6.3

By Type of Drug, By Value (2013-2017)

124

7.6.4

By Type of Drug, By Value (2018-2023)

125

7.6.5

By Route of Administration, By Value (2013-2017)

126

7.6.6

By Route of Administration, By Value (2018-2023)

127

APAC Chemotherapy Drugs Market: Country Analysis (India and China)

128

7.7.1

India Chemotherapy Drugs Market, By Value (2013-2023)

130

7.7.2

China Chemotherapy Drugs Market, By Value (2013-2023)

136

ROW Chemotherapy Drugs Market: Growth and Forecast

143

7.8.1

By Value (2013-2017)

144

7.8.2

By Value (2018-2023)

144

8

Table of Content S.No

8.

9.

Particulars

Page No.

7.8.3

By Type of Drug, By Value (2013-2017)

149

7.8.4

By Type of Drug, By Value (2018-2023)

150

7.8.5

By Route of Administration, By Value (2013-2017)

151

7.8.6

By Route of Administration, By Value (2018-2023)

152

Global Chemotherapy Drugs Market Dynamics

153

8.1

Global Chemotherapy Drugs Market Drivers

154

8.2

Global Chemotherapy Drugs Market Restraints

158

Global Chemotherapy Drugs Market Trends

161

10.

Porter Five Force Analysis

162

11.

SWOT Analysis

164

12.

Policy and Regulatory Landscape

166

9

Table of Content S.No

14.

15.

Particulars

Company Profiling

Page No.

177

14.1

Pfizer

178

14.2

Eli Lilly & Company

181

14.3

CELGENE Corporation

183

14.4

Bristol-Myers Squibb

186

14.5

Merck & Co., Inc.

188

14.6

GlaxoSmithKline plc

190

14.7

Novartis

192

14.8

Sanofi

194

14.9

Teva Pharmaceuticals Industries Limited

196

About Us

198

10

List of Figures Figure No.

Figure Title

Page No.

Figure 1:

Common Treatment Modalities for Cancer

11

Figure 2:

Cancer Treatment Flowchart

28

Figure 3:

Chemotherapy Drugs Market Segmentation Flowchart

33

Figure 4:

Global Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)

35

Figure 5:

Global Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)

36

Figure 6:

Key factors driving of change in the global oncology market

37

Figure 7:

Projected global population (In Billions)

38

Figure 8:

Population ages 65 and above, By Select Region, 2013-2017 (% of total)

38

Figure 9:

Projected global population aged 60 years & above (In Billions)

38

Figure 10:

Global Health Expenditure Per Capita, By Select Countries, 2016 (In USD)

39

Figure 11:

Global Health Expenditure Per Capita, (2012-2016, USD Trillion)

39

Figure 12:

Global Burden of Cancer

40

Figure 13:

Prevalence and Epidemiology of Cancer Worldwide

41

Figure 14:

5 Year Survival Rate, Breast and Colorectal Cancer

41

Figure 15:

Types of cancer for which clinical trials using chemotherapy drugs treatment are being conducted

42

Figure 16:

Global Prevalence of Different Type of Cancer, 2017 (In Thousands)

43

Figure 17:

Global Prevalence of Prostate Cancer (2013-2017, Thousands)

43

Figure 18:

Oncologists per 1 Million of Population, By Select Country, 2018

44

Figure 19:

Availability of New Cancer Drugs Launched in 2012-2016, By Select Country (As of 2017)

45

Figure 20:

Global Antimetabolite Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)

49

11

List of Figures Figure No.

Figure Title

Page No.

Figure 21:

Global Antimetabolite Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

49

Figure 22:

Global Plant Alkaloid Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)

50

Figure 23:

Global Plant Alkaloid Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

50

Figure 24:

Global Alkylating Agent Drugs Market, By Value, 2013-2017 (USD Million)

51

Figure 25:

Global Alkylating Agent Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

51

Figure 26:

Global Anti-tumor Antibiotic Drugs Market, By Value, 2013-2017 (USD Million)

52

Figure 27:

Global Anti-tumor Antibiotic Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

52

Figure 28:

Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)

53

Figure 29:

Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

53

Figure 30:

Global Chemotherapy Drugs Market Size, By Route of Administration, 2017 (%)

55

Figure 31:

Global Chemotherapy Drugs Market Size,By Route of Administration, 2023 (%)

56

Figure 32:

Global Intravenous Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)

57

Figure 33:

Global Intravenous Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

57

Figure 34:

Global Oral Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)

58

Figure 35:

Global Oral Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

58

Figure 36:

Other Chemotherapy Drugs Market, By Value, 2013-2017 (USD Million)

59

Figure 37:

Other Chemotherapy Drugs Market, By Value, Forecast, 2018-2023 (USD Million)

59

Figure 38:

Global Chemotherapy Drugs Market Size, By Region, 2017 (%)

62

Figure 39:

Global Chemotherapy Drugs Market Size, By Region, 2023 (%)

63

Figure 40:

North America Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)

65

12

List of Figures Figure No.

Figure Title

Page No.

Figure 41:

North America Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)

66

Figure 42:

North America GDP, 2012-2017 (USD Trillion)

68

Figure 43:

North America GDP per capita, current prices, 2013-2023F (In USD)

68

Figure 44:

Prevalence of Different Type of Cancer in North America in year 2016 & 2017 ( In Hundreds)

69

Figure 45:

North America, Cancer Incidence (In Millions)

70

Figure 46:

North America, Cancer Incidence, By Route of Administration, 2019E (In %)

70

Figure 47:

North America Population above 65 year, 2015, 2030F, & 2050F (In Millions)

70

Figure 48:

North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)

72

Figure 49:

North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)

73

Figure 50:

North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)

74

Figure 51:

North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)

75

Figure 52:

U.S. Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

78

Figure 53:

Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)

79

Figure 54:

Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)

79

Figure 55:

Leading Sites of New Cancer Cases in the United States amongst Males, 2018 (In %)

80

Figure 56:

Estimated New Cases of Cancer in the United States, 2014-2018 (In Thousands)

80

Figure 57:

Estimated New Cases of Cancer in the United States, By State, 2018

81

Figure 58:

Estimated Numbers of US Cancer Survivors (As of January 1, 2016)

82

Figure 59:

Estimated Numbers of US Cancer Survivors (As of January 1, 2026F)

83

Figure 60:

Factors Influencing Patient Out-of-Pocket Costs for Cancer Medicines

84

List of Figures Figure No.

Figure Title

Page No.

Figure 61:

United States, Top Players in the chemotherapy drugs market, By Company Share, 2017 (%)

85

Figure 62:

Canada Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

86

Figure 63:

Cancer Burden in Canada, 2017

87

Figure 64:

Prevalence of Different Type of Cancer in Canada, 2016 & 2017 ( In Hundreds)

88

Figure 65:

Cancer Fact Sheet of Canada, 2017

88

Figure 66:

Canada, Expenditure on Health as a share of GDP, 2012-2017 (In %)

89

Figure 67:

Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)

89

Figure 68:

North America Chemotherapy Drugs Market, Country Share, 2013-2017 (% of Total)

90

Figure 69:

North America Chemotherapy Drugs Market, Country Share, 2018F-2023F (% of Total)

91

Figure 70:

Europe Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)

93

Figure 71:

Europe Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)

94

Figure 72:

Europe, Cancer Incidence, 2019E-2035F (In Millions)

95

Figure 73:

Europe, Cancer Incidence, By Type, 2019E

95

Figure 74:

Prevalence of Different Type of Cancer in Western Europe in year 2016 & 2017 ( In Thousands)

96

Figure 75:

Europe, Per Capita Health Expenditure, By Select Country, 2017 (USD)

97

Figure 76:

GDP, Europe Region, By Select Country, 2017 (In Trillion USD)

97

Figure 77:

Breakdown of Total Health Expenditure in Europe, 2018 (%)

98

Figure 78:

Major Players in Chemotherapy Drugs Market in Europe

98

Figure 79:

Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)

100

Figure 80:

Europe Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)

101

List of Figures Figure No.

Figure Title

Page No.

Figure 81:

Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)

102

Figure 82:

Europe Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)

103

Figure 83:

Germany Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

106

Figure 84:

Germany, Health Expenditure Per Capita, PPP, 2012-2017 (USD)

108

Figure 85:

Prevalence of Different Type of Cancer in Germany in year 2016 & 2017 ( In Hundreds)

109

Figure 86:

U.K Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

111

Figure 87:

Cancer Statistics in the United Kingdom

112

Figure 88:

U.K, Health Expenditure Per Capita, PPP, 2012-2017 (USD)

113

Figure 89:

Europe Chemotherapy Drugs Market, Country Share, Historic, 2013-2017(% of Total)

114

Figure 90:

Europe Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)

115

Figure 91:

APAC Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million)

117

Figure 92:

APAC Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million)

118

Figure 93:

Estimated number of deaths from prostate cancer in 2012 and 2030

120

Figure 94:

World health expenditure as % of GDP

120

Figure 95:

Population ages 65 and above, APAC Region, By Select Countries, 2017 (% of total)

121

Figure 96:

Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)

121

Figure 97:

APAC, GDP, By Select Country, 2017 (In USD Trillion)

121

Figure 98:

APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)

124

Figure 99:

APAC Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)

125

APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)

126

Figure 100:

15

List of Figures Figure No.

Figure Title

Page No.

Figure 101:

APAC Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)

127

Figure 102:

India Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

130

Figure 103:

Key factors affecting the Indian Healthcare Industry

131

Figure 104:

India, Total Population, 2013-2023F (In Billion)

132

Figure 105:

India, Share of Urban Population, 2012-2017 (In %)

132

Figure 106:

India, GDP Growth Per Year, 2015-2019 (In %)

133

Figure 107:

India, Total deaths due to cancer, 2018

133

Figure 108:

Top 5 forms of cancer in men and women in India

133

Figure 109:

China Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

136

Figure 110:

China, GDP Growth Per Year, 2015-2019 (In %)

137

Figure 111:

China, Share of Urban Population, 2012-2017 (In %)

137

Figure 112:

China, Total Population, 2013-2021F (In Billion)

137

Figure 113:

Prevalence of Different Type of Cancer in China in year 2016 & 2017 ( In Hundreds)

138

Figure 114:

Number of new cases, Males (all ages), 2018 (In %)

139

Figure 115:

Number of new cases, Females (all ages), 2018 (In %)

139

Figure 116:

China, Cancer Mortality Rate, By Cancer Site, 2018

140

Figure 117:

APAC Chemotherapy Drugs Market, Country Share, Historic, 2013-2017 (% of Total)

141

Figure 118:

APAC Chemotherapy Drugs Market, Country Share, Forecast, 2018-2023 (% of Total)

142

Figure 119:

ROW Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

144

Figure 120:

Middle East and North Africa, GDP, 2012-2017 (In USD Trillion)

145

16

List of Figures Figure No.

Figure Title

Page No.

Figure 121:

Latin America and Caribbean, Share of Urban Population in Total Population, 2012-2017 (In %)

145

Figure 122:

Prevalence of Different Type of Cancer in Middle East and North Africa in year 2016 & 2017 ( In Hundreds)

146

Figure 123:

Prevalence of Different Type of Cancer in Brazil in year 2016 & 2017 ( In Hundreds)

147

Figure 124:

ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million)

149

Figure 125:

ROW Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million)

150

Figure 126:

ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)

151

Figure 127:

ROW Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)

152

Figure 128:

Drug Discovery and Development, Approximate Timeline

176

Figure 129:

Pfizer, Revenue, 2013-2017 (In USD Billion)

179

Figure 130:

Pfizer, Revenue, By Business Segment, 2017 (In %)

179

Figure 131:

Pfizer, Revenue, By National Market, 2015-2017 (In %)

179

Figure 132:

Pfizer, Oncology Revenue, 2015-2017 (In USD Million)

180

Figure 133:

Eli Lilly & Company, Revenue, 2013-2017 (In USD Billion)

182

Figure 134:

Eli Lilly & Company, Revenue, By Business Segment, 2017 (In %)

182

Figure 135:

Eli Lilly & Company, Net Sales, By Geographic Region, 2017 (In %)

182

Figure 136:

CELGENE Corporation, Revenue, 2013-2017 (In USD Million)

184

Figure 137:

CELGENE Corporation, Net Sales, By Geographic Region, 2017 (In %)

184

Figure 138:

Bristol-Myers Squibb, Revenue, 2013-2017 (In USD Million)

187

Figure 139:

Bristol-Myers Squibb, Revenue, By Business Segment, 2017 (In %)

187

Figure 140:

Bristol-Myers Squibb, Net Sales, By Geographic Region, 2017 (In %)

187

17

List of Figures Figure No.

Figure Title

Page No.

Figure 141:

Merck & Co., Inc., Revenue, 2013-2017 (In USD Million)

189

Figure 142:

Merck & Co., Inc., Net Sales, By Geographic Region, 2017 (In %)

189

Figure 143:

GlaxoSmithKline plc, Revenue, 2013-2017 (In USD Million)

191

Figure 144:

GlaxoSmithKline plc, Revenue, By Business Segment, 2017 (In %)

191

Figure 145:

GlaxoSmithKline plc, Net Sales, By Geographic Region, 2017 (In %)

191

Figure 146:

Novartis, Revenue, 2014-2018 (In USD Million)

193

Figure 147:

Novartis, Net Sales, By Business Segment, 2017 (In %)

193

Figure 148:

Sanofi, Revenue, 2013-2017 (In USD Million)

195

Figure 149:

Sanofi , Revenue, By Business Segment, 2017 (In %)

195

Figure 150:

Sanofi, Net Sales, By Geographic Region, 2017 (In %)

195

Figure 151:

Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, 2013-2017 (In USD Million)

197

Figure 152:

Teva Pharmaceutical INDUSTRIES LIMITED, Revenue, By Business Segment, 2017 (In %)

197

Figure 153:

Teva Pharmaceutical INDUSTRIES LIMITED, Net Sales, By Geographic Region, 2017 (In %)

197

Table A:

Approach and Limitations of Common Treatment Modalities for Cancer

27

Table B:

Recent Company Acquisitions and Mergers in Chemotherapy Drugs Market

46

Table C:

Germany, Healthcare Related Statistics, 2017

108

Table D:

Estimated number of people living with cancer, 2020F and 2030F

113

Table E:

Global Access to Healthcare Index, Ranking of Select Countries in Asia Pacific Region, 2017 (score out of 10)

122

Table F:

India, Cancer Statistics

134

18

Research Methodology For our study on global chemotherapy drugs market, we have conducted comprehensive secondary research followed by an extensive primary research. In the process of

secondary research, we have scrutinized

industry documents, accessed from open sources, premium paid databases (Bloomberg, Thomson Reuters, Factiva) and our internal knowledge base. In the process of primary research, we have interviewed various industry experts across the value chain of pharmaceutical and healthcare industry.

Market size of the actual period (2013-2017) has been evaluated on the basis of growth trends of the industry in the last five years, and confirming the findings through primary research. Annual reports of the companies were scanned to further validate the market size and to estimate the size of various other

end-user sectors. Market sizing and growth in the forecast period (2018-2023) is estimated through product mapping, application in end-user industries, growth of allied sectors and historical growth pattern of the industry. All the relevant data points/ statistics in the forecast period are validated through relevant and reliable primary sources.

Report Focus: Global Chemotherapy Drugs Market - By Type of Drug (Antimetabolites, Plant Alkaloids, Alkylating Agents, Antitumor Antibiotics and Others) - By Route of Administration (Oral, Intravenous and Others) - By Region (North America, Europe, Asia Pacific and Rest of the World) - By Country ( U.S., Canada, U.K, Germany, China and India).

Companies Contacted: Eli Lilly & Company, Shilpa Medicare

19

Chemotherapy Drugs Market: Product Outlook Figure 2: Cancer Treatment Flowchart

PreCancer

Screening Diagnostics

Cancer

Companion Diagnostics

Immuno-therapy

Targeted Drugs

Surgery

Chemotherapy

Radiotherapy

Source: Azoth Analytics Estimates

20

Chemotherapy Drugs Market: Product Outlook Figure 3: Chemotherapy Drugs Market Segmentation Flowchart

Antimetabolites

Plant Alkaloids

By Type of Drug

Alkylating Agents

Antitumor Antibiotics

Others

Chemotherapy Drugs Market

Oral

By Route of Administration

Intravenous

Others Source: Azoth Analytics Estimates

21

Global Chemotherapy Drugs Market Overview Rapidly growing incidence of cancer worldwide in concurrence with rising expenditure on healthcare has been boosting the chemotherapy drugs market on a global level.

Figure 4: Global Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million) CAGR 2013-2017 xx%

2013

2014

2015

2016

2017

Source: Azoth Analytics Estimates Xx Xx

Xx Xx Xx Xx

22

Global Chemotherapy Drugs Market Rising availability of lower priced generic versions of blockbuster chemotherapy drugs across the globe is likely to drive the demand growth in the forecast period.

Figure 5: Global Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million) CAGR 2018-2023 xx%

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx

23

Global Antimetabolite Drugs Market Global Chemotherapy Drugs Market Chemotherapy Replacement Devices Market, By Value Figure 20: Global Antimetabolite Chemotherapy

Figure 21: Global Antimetabolite Chemotherapy Drugs

Drugs Market, By Value, 2013-2017 (USD Million)

Market, By Value, Forecast, 2018-2023 (USD Million)

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx

Xx Xx Xx Xx Xx

24

Global Plant Drugs Market Global Chemotherapy DrugsAlkaloid MarketChemotherapy Replacement Devices Market, By Value Figure 22: Global Plant Alkaloid Chemotherapy Drugs

Figure 23: Global Plant Alkaloid Chemotherapy Drugs

Market, By Value, 2013-2017 (USD Million)

Market, By Value, Forecast, 2018-2023 (USD Million)

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx

Xx Xx Xx Xx Xx

25

Drugs Market Global ChemotherapyGlobal DrugsAlkylating Market Agent Replacement Devices Market, By Value Figure 24: Global Alkylating Agent Drugs Market, By

Figure 25: Global Alkylating Agent Drugs Market, By

Value, 2013-2017 (USD Million)

Value, Forecast, 2018-2023 (USD Million)

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx

Xx Xx Xx Xx Xx

26

Global Anti-tumor Drugs Market Global Chemotherapy Drugs Market Antibiotic Replacement Devices Market, By Value Figure 26: Global Anti-tumor Antibiotic Drugs Market,

Figure 27: Global Anti-tumor Antibiotic Drugs Market,

By Value, 2013-2017 (USD Million)

By Value, Forecast, 2018-2023 (USD Million)

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx

Xx Xx Xx Xx Xx

27

Other Chemotherapy Drugs Market Global Chemotherapy Drugs Market Replacement Devices Market, By Value Figure 28: Other Chemotherapy Drugs Market, By

Figure 29: Other Chemotherapy Drugs Market, By

Value, 2013-2017 (USD Million) CAGR 2013-2017

Value, Forecast, 2018-2023 (USD Million) CAGR 2018-2023

xx%

xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Xx Xx

Source: Azoth Analytics Estimates

Xx

Xx Xx Xx Xx Xx

28

Global Chemotherapy Drugs Market- By Route of Administration Intravenously administered chemotherapy drugs held the major market share of approximately 75.58%, by value, in the year 2017.

Key Drivers Figure 30: Global Chemotherapy Drugs Market Size,

By Route of Administration, 2017 (%) xx

Oral

Intravenous

xx

Others

Source: Azoth Analytics Estimates xx

29

Global Chemotherapy Drugs Market- By Route of Administration In the forecast period, the segment of orally administered chemotherapy drugs is expected to witness fastest growth.

Key Drivers

Figure 31: Global Chemotherapy Drugs Market Size,

By Route of Administration, 2023 (%) xx

Oral

Intravenous

xx

Others

xx Source: Azoth Analytics Estimates

30

GlobalDrugs Intravenous Chemotherapy Drugs MarketMarket, By Value Global Chemotherapy Market Replacement Devices Figure 32: Global Intravenous Chemotherapy Drugs

Figure 33: Global Intravenous Chemotherapy Drugs

Market, By Value, 2013-2017 (USD Million)

Market, By Value, Forecast, 2018-2023 (USD Million)

2013

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Xx Source: Azoth Analytics Estimates Xx Xx

Xx Xx Xx Xx Xx

31

Global Oral Chemotherapy Drugs Market Global Chemotherapy Drugs Market Replacement Devices Market, By Value Figure 34: Global Oral Chemotherapy Drugs Market,

Figure 35: Global Oral Chemotherapy Drugs Market,

By Value, 2013-2017 (USD Million)

By Value, Forecast, 2018-2023 (USD Million)

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2013

Xx

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates

Xx Xx

Xx Xx Xx Xx Xx

32

Other Chemotherapy Drugs Market Global Chemotherapy Drugs Market Replacement Devices Market, By Value Figure 36: Other Chemotherapy Drugs Market, By

Figure 37: Other Chemotherapy Drugs Market, By

Value, 2013-2017 (USD Million)

Value, Forecast, 2018-2023 (USD Million)

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

Xx Xx

Source: Azoth Analytics Estimates

Xx Xx Xx Xx Xx Xx

33

Global Chemotherapy Drugs Market- Regional Analysis Developed regions such as North America and Europe held more than 70% share in the global chemotherapy drugs market, by value, in the year 2017.

Key Drivers

Figure 38: Global Chemotherapy Drugs Market Size,

By Region, 2017 (%) xx

North America

Europe xx

APAC

ROW xx Source: Azoth Analytics Estimates

34

Global Chemotherapy Drugs Market- Regional Analysis In the forecast period, North America region is expected to hold it’s dominant position in the market.

However, Asia-Pacific market is anticipated to advance at the highest pace.

Figure 39: Global Chemotherapy Drugs Market

Key Drivers

Size, By Region, 2023 (%)

xx

North America

Europe

xx

APAC

ROW xx Source: Azoth Analytics Estimates

35

North America Chemotherapy Drugs Market Overview Heavy investments in the research & development of innovative chemotherapy drugs together with high per capita expenditure on healthcare have been the key factors backing the regional market.

Figure 40: North America Chemotherapy Drugs Market Size, By Value, 2013-2017 (USD Million) CAGR 2013-2017 xx%

2013

Xx

2014

2015

2016

2017

Source: Azoth Analytics Estimates

Xx

Xx Xx Xx Xx

36

North America Chemotherapy Drugs Market Overview Noteworthy growth in the regional market is attributed to favourable reimbursement policies in the region in addition to high focus on international sales, mergers and acquisitions.

Figure 41: North America Chemotherapy Drugs Market Size, By Value, Forecast, 2018-2023 (USD Million) CAGR 2018-2023 xx%

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates Xx Xx Xx Xx Xx Xx

37

North America Chemotherapy Drugs Market, By Type of Drug Figure 48: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2013-2017 (USD Million) CAGR 2013-2017 Antimetabolites: xx% Plant Alkaloids: xx%

Alkylating Agents: xx% Antitumor Antibiotics : xx% Others: xx%

2013

Antimetabolites

2014

2015

Plant Alkaloids

2016

Alkylating Agents

2017

Anti-tumor Antibiotics

Others

2013

2014

2015

2016

2017

Antimetabolites

xx

xx

xx

xx

xx

Plant Alkaloids

xx

xx

xx

xx

xx

Alkylating Agents

xx

xx

xx

xx

xx

Antitumor Antibiotics

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

Xx Xx Xx Xx Source: Azoth Analytics Estimates

38

North America Chemotherapy Drugs Market, By Type of Drug Figure 49: North America Chemotherapy Drugs Market: By Type of Drug, By Value, 2018E-2023F (USD Million) CAGR 2018-2023 Antimetabolites: xx% Plant Alkaloids: xx%

Alkylating Agents: xx% Antitumor Antibiotics : xx% Others: xx%

2018 Antimetabolites

2019

2020

Plant Alkaloids

2021 Alkylating Agents

2022

2023

Anti-tumor Antibiotics

Others

2018

2019

2020

2021

2022

2023

Antimetabolites

xx

xx

xx

xx

xx

xx

Plant Alkaloids

xx

xx

xx

xx

xx

xx

Alkylating Agents

xx

xx

xx

xx

xx

xx

Antitumor Antibiotics

xx

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

xx

Xx Xx Xx

Source: Azoth Analytics Estimates

39

North America Chemotherapy Drugs Market, By Route of Administration Figure 50: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2013-2017 (USD Million)

CAGR 2013-2017 Oral: xx% Intravenous: xx% Others: xx%

2013

2014

2015

Oral

2016

Intravenous

2017 Others

2013

2014

2015

2016

2017

Oral

xx

xx

xx

xx

xx

Intravenous

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

40

North America Chemotherapy Drugs Market, By Route of Administration Figure 51: North America Chemotherapy Drugs Market: By Route of Administration, By Value, 2018E-2023F (USD Million)

CAGR 2018-2023 Oral: xx% Intravenous: xx% Others: xx%

2018

2019

2020

Oral

2021

2022

Intravenous

2023

Others

2018

2019

2020

2021

2022

2023

Oral

xx

xx

xx

xx

xx

xx

Intravenous

xx

xx

xx

xx

xx

xx

Others

xx

xx

xx

xx

xx

xx

Xx Xx Xx Xx

Source: Azoth Analytics Estimates

41

U.S. Chemotherapy Drugs Market, By Value Figure 52: U.S. Chemotherapy Drugs Market Size, By Value, 2013-2023 (USD Million)

2013

Xx

2014

CAGR 2013-2017

CAGR 2018-2023

xx%

xx%

2015

2016

2017

2018

2019

2020

2021

2022

2023

Source: Azoth Analytics Estimates

Xx Xx

Xx Xx •

.

Xx Xx Xx

42

About Azoth Analytics Pvt Ltd.

Azoth Analytics (ISO 9001:2015) is a business research and analytics company that creates in-depth research reports and provides customized research solutions and consulting services. An ISO 9001:2015 certified company, Azoth Analytics adheres to international quality management standard and has strong commitment to a culture of continuous improvement. The business research and market analysis of Azoth Analytics helps organizations across different industry verticals solve their business problems. Strategic market sizing and data dredging techniques include secondary research, and primary research

(interviews with management personnel and industry experts). Azoth Analytics provide syndicated and customized market research reports on different verticals including pharmaceutical and healthcare, oil and gas and power, chemicals, automotive, technology, FMCG, food & beverages and media sectors.

(c) AZOTH Analytics

43